Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up). [electronic resource]
Producer: 20170427Description: 54-58 p. digitalISSN:- 1873-2763
- Aged
- Alendronate -- therapeutic use
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Denosumab -- therapeutic use
- Diphosphonates -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Ibandronic Acid
- Imidazoles -- therapeutic use
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Postmenopause
- Teriparatide -- therapeutic use
- Zoledronic Acid
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.